e-learning
resources
ERJ
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide
Homma S., Miyamoto A., Sakamoto S., Kishi K., Motoi N., Yoshimura K.
Source:
Eur Respir J 2005; 25: 200-204
Journal Issue:
January
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Homma S., Miyamoto A., Sakamoto S., Kishi K., Motoi N., Yoshimura K.. Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide. Eur Respir J 2005; 25: 200-204
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Occupational and drug-induced ILDs
PG16 Advanced cardiopulmonary exercise testing
Related content which might interest you:
Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments
Source: Eur Respir J 2009; 34: 117-124
Year: 2009
Exhaled nitric oxide is not reduced in infants with cystic fibrosis
Source: Eur Respir J 2006; 27: 350-354
Year: 2006
NiO and Co3O4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis
Source: Eur Respir J 2012; 39: 546-557
Year: 2012
Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide
Source: Eur Respir J 2007; 30: 26-30
Year: 2007
Exhaled nitric oxide in respiratory diseases other than asthma
Source: Eur Respir Monogr 2010; 49: 45-55
Year: 2010
Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients
Source: Eur Respir J 2009; 34: 138-144
Year: 2009
Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients
Source: Eur Respir J 2001; 17: 1267-1270
Year: 2001
Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Interstitial pulmonary disorders in indium-processing workers
Source: Eur Respir J 2007; 29: 317-324
Year: 2007
Bronchial but not alveolar nitric oxide is decreased in adults with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005
Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment
Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018
Year: 2019
Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity
Year: 2016
Airway acidification and exhaled nitric oxide in cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 514s
Year: 2003
Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis
Source: Eur Respir J 2002; 20: 92-99
Year: 2002
Exhaled nitric oxide after lung transplantation: impact of the native lung
Source: Eur Respir J 2003; 21: 429-432
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept